Stifel Financial Corp Adamis Pharmaceuticals Corp Transaction History

Stifel Financial Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$0.66 - $1.23 $26,400 - $49,200	-40,000 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$0.54 - $1.79 $21,600 - $71,600	40,000 New	40,000 $38,000
Q3 2020 Nov 16, 2020	SELL	$0.52 - $1.45 $5,200 - $14,500	-10,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$0.33 - $0.66 $3,300 - $6,600	10,000 New	10,000 $5,000

Ticker ADMP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 149,983,008
Market Cap $73.5M
Description
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Stifel Financial Corp with notifications on news.